A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
- Danielle K. DePalo
- , Michelle M. Dugan
- , Syeda Mahrukh Hussnain Naqvi
- , David W. Ollila
- , Tina J. Hieken
- , Matthew S. Block
- , Winan J. van Houdt
- , Michel W.J.M. Wouters
- , Sophie J.M. Reijers
- , Nethanel Asher
- , Kristy K. Broman
- , Zoey Duncan
- , Matilda Anderson
- , David E. Gyorki
- , Hayden Snow
- , Jenny Held
- , Jeffrey M. Farma
- , John T. Vetto
- , Jane Y.C. Hui
- , Madison Kolbow
- Moffitt Cancer Center
- University of North Carolina at Chapel Hill
- Mayo Clinic
- Netherlands Cancer Institute
- Rabin Medical Center Israel
- University of Alabama at Birmingham
- U.S. Department of Veterans Affairs
- Peter Maccallum Cancer Centre
- University of Melbourne
- Fox Chase Cancer Center
- Oregon Health and Science University
- University of Minnesota Twin Cities
- University of Sydney
- Royal North Shore and Mater Hospitals
- Royal Prince Alfred Hospital
- Sahlgrenska University Hospital
- University of Gothenburg
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations